Literature DB >> 19138553

Effector protein modulation of host cells: examples in the Chlamydia spp. arsenal.

Helen J Betts1, Katerina Wolf, Kenneth A Fields.   

Abstract

As obligate intracellular parasites, Chlamydia spp. must create and maintain a specialized intracellular niche while simultaneously contending with potent host defenses. Discoveries that chlamydiae deploy an array of anti-host proteins have placed new emphasis on deciphering the impact of host cell biology on chlamydial development and virulence. Recent advances in the understanding of chlamydial pathogenesis are exemplified by work describing potential roles of (i) chlamydial Tarp in invasion, (ii) Inc proteins in modulation of vesicular interactions, and (iii) chlamydial proteins in disregulation of NF-kappaB signal transduction. Characterization of these chlamydial effector proteins promises to answer old questions and reveals previously unappreciated biology. The challenge will be to determine how these molecular mechanisms mesh together and collectively contribute to Chlamydia-mediated disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19138553     DOI: 10.1016/j.mib.2008.11.009

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  49 in total

1.  cPLA2 regulates the expression of type I interferons and intracellular immunity to Chlamydia trachomatis.

Authors:  Mark J Vignola; David F Kashatus; Gregory A Taylor; Christopher M Counter; Raphael H Valdivia
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  Identification of a family of effectors secreted by the type III secretion system that are conserved in pathogenic Chlamydiae.

Authors:  Sandra Muschiol; Gaelle Boncompain; François Vromman; Pierre Dehoux; Staffan Normark; Birgitta Henriques-Normark; Agathe Subtil
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms.

Authors:  Hector A Saka; J Will Thompson; Yi-Shan Chen; Yadunanda Kumar; Laura G Dubois; M Arthur Moseley; Raphael H Valdivia
Journal:  Mol Microbiol       Date:  2011-11-07       Impact factor: 3.501

4.  Coxiella burnetii effector proteins that localize to the parasitophorous vacuole membrane promote intracellular replication.

Authors:  Charles L Larson; Paul A Beare; Daniel E Voth; Dale Howe; Diane C Cockrell; Robert J Bastidas; Raphael H Valdivia; Robert A Heinzen
Journal:  Infect Immun       Date:  2014-11-24       Impact factor: 3.441

5.  Altered protein secretion of Chlamydia trachomatis in persistently infected human endocervical epithelial cells.

Authors:  Jin Wang; Kyla M Frohlich; Lyndsey Buckner; Alison J Quayle; Miao Luo; Xiaogeng Feng; Wandy Beatty; Ziyu Hua; Xiancai Rao; Maria E Lewis; Kelly Sorrells; Kerri Santiago; Guangming Zhong; Li Shen
Journal:  Microbiology (Reading)       Date:  2011-07-07       Impact factor: 2.777

6.  Transcription factor complex AP-1 mediates inflammation initiated by Chlamydia pneumoniae infection.

Authors:  Anyou Wang; Mufadhal Al-Kuhlani; S Claiborne Johnston; David M Ojcius; Joyce Chou; Deborah Dean
Journal:  Cell Microbiol       Date:  2012-12-16       Impact factor: 3.715

Review 7.  A working model for the type III secretion mechanism in Chlamydia.

Authors:  Joshua C Ferrell; Kenneth A Fields
Journal:  Microbes Infect       Date:  2015-10-26       Impact factor: 2.700

8.  The arginine-rich N-terminal domain of ROP18 is necessary for vacuole targeting and virulence of Toxoplasma gondii.

Authors:  Sarah J Fentress; Tobias Steinfeldt; Jonathan C Howard; L David Sibley
Journal:  Cell Microbiol       Date:  2012-09-20       Impact factor: 3.715

9.  Chlamydia trachomatis intercepts Golgi-derived sphingolipids through a Rab14-mediated transport required for bacterial development and replication.

Authors:  Anahí Capmany; María Teresa Damiani
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

10.  The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis.

Authors:  John D Carter; Herve C Gerard; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Int J Clin Rheumtol       Date:  2012-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.